HEPA Chart
- 52-Week Range: $0.65 - $2.26
- Market Capitalization: $55.15M
- Short Percentage: 0%
- Target Price: $4.75
- Shares Outstanding: 76.23M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
HEPA released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Hepion Pharmaceuticals Announces USAN Selection of “Rencofilstat” as Nonproprietary Name for CRV431GlobeNewsWire | January 6th
- Hepion Pharmaceuticals Announces Participation in the H.C. Wainwright BioConnect ConferenceGlobeNewsWire | January 5th
- Hepion Pharmaceuticals to Present Clinical Data at NASH-TAG ConferenceGlobeNewsWire | January 5th
- Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver CancerGlobeNewsWire | December 21st
- Hepion Pharmaceuticals and FibroFind Announce Anti-Cancer Activity of CRV431 in a Nonclinical Liver Cancer StudyGlobeNewsWire | November 16th
- All Endpoints Met in Hepion Pharmaceuticals' Drug-Drug Interaction Study with CRV431GlobeNewsWire | September 29th
- Additional Phase IIa Data Confirms Hepion's CRV431 As A Very Promising NASH Candidate DrugSeeking Alpha | September 21st
Company Info
Website: https://www.hepionpharma.com
Address: 399 Thornall Street, Edison, NJ, United States, 08837
Sector: Healthcare
Industry: Biotechnology
Full time employees: 20
Address: 399 Thornall Street, Edison, NJ, United States, 08837
Sector: Healthcare
Industry: Biotechnology
Full time employees: 20
$HEPA hi hi
$HEPA today feels different to the moon
$HEPA Come on.. Let it fall.. buy later bulls
$HEPA hold and buy… go green go!!!
$HEPA I do it for the thrills!
$HEPA buy and hodl friends. we may be early
but we are not wrong. very soon.
$HEPA Many many bears
$HEPA I like it
$HEPA time to short this
$HEPA I can wait.